Search

everythinglearnresearchcommunity

for

Search:↓

CRISPR/Cas systems show promise for cancer treatment by targeting miRNAs, but delivery and specificity challenges remain.

The new skin-targeted COVID-19 vaccine creates strong immune responses and could improve vaccination methods.

The research suggests new treatments for skin cancer could target specific cell growth pathways.

Baricitinib was effective in treating alopecia areata in two major trials.

Cyclosporin A and FK506 can start new hair growth in mice, but ascomycin and rapamycin cannot.

A new cream, DHMEQ, reduces allergic skin inflammation effectively.

Telitacicept effectively improved hair regrowth in a woman with lupus and alopecia.

Ritlecitinib helps reduce inflammation and promote hair regrowth in alopecia areata, especially in patchy-type cases.

COVID-19 infection rates were low in patients with immune diseases, regardless of their treatment type.

Combining ATRA with TPO-RA effectively stabilizes platelet counts in ITP patients.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

Switching between the medications tofacitinib and baricitinib can be effective for treating hair loss in alopecia areata.

Monoclonal antibodies LT-1, LT-2, and LT-7 help diagnose certain blood cancers.

Baricitinib successfully treated myasthenia gravis and alopecia in a patient.

Baricitinib helps regrow hair and improves quality of life and mental health in severe alopecia areata patients.

The document doesn't provide a clear conclusion or detailed findings about the impact of certain cells on cancer treatment.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

PX-12 may help treat psoriasis by blocking inflammation and cell death.

Ocrelizumab may cause pancreatitis in some patients.

Immunoadsorption successfully treated a man's resistant polymyositis.

Upadacitinib effectively treated severe atopic dermatitis, vitiligo, and alopecia areata in one patient.

JAK inhibitors may help treat alopecia areata and promote hair regrowth.

Selective immunotherapies like anifrolumab and belimumab are more effective for treating systemic lupus erythematosus than traditional drugs.

Upadacitinib helped regrow hair and maintain ulcerative colitis remission.

Sirolimus and propranolol may reduce abnormal cell growth and improve lymphatic malformations in children.

Targeting CD169+ skin macrophages may help treat psoriasis.

EGFR and MEK inhibitors reduce PD-L1 in hair follicles, possibly causing inflammation.

JAK inhibitors are effective for severe alopecia areata but need better strategies for long-term use and personalized treatment.

Clonally expanded CD8+ T cells cause alopecia areata.